| Schedule of computation of basic and diluted net income (loss) per share |
| | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | | | 2026 | | 2025 | | | 2026 | | 2025 | | | Numerator: | | | | | | | | | | | | | | | | | Net income (loss), basic | | $ | 83,496 | | $ | (64,849) | | | | $ | 80,687 | | $ | 801,713 | | | Add: Interest expense, net of tax, on the Company's 2026 and 2031 Convertible Notes | | | 959 | | | — | | | | | 2,045 | | | 2,161 | | | Net income (loss), diluted | | $ | 84,455 | | $ | (64,849) | | | | $ | 82,732 | | $ | 803,874 | | | Denominator: | | | | | | | | | | | | | | | | | Weighted-average number of shares outstanding, basic | | | 83,006,808 | | | 78,151,240 | | | | | 82,765,248 | | | 78,438,830 | | | Effect of dilutive securities: | | | | | | | | | | | | | | | | | Common stock issuable under the Company's equity incentive plans | | | 3,551,404 | | | — | | | | | 3,591,103 | | | 2,589,633 | | | Common stock issuable under the Company's 2026 and 2031 Convertible Notes | | | 5,461,797 | | | — | | | | | 5,467,922 | | | 5,474,115 | | | Weighted-average common shares outstanding, diluted | | | 92,020,009 | | | 78,151,240 | | | | | 91,824,273 | | | 86,502,578 | | | Net income (loss) per common share, basic | | $ | 1.01 | | $ | (0.83) | * | | | $ | 0.97 | | $ | 10.22 | | | Net income (loss) per common share, diluted | | $ | 0.92 | | $ | (0.83) | * | | | $ | 0.90 | | $ | 9.29 | | |
* In the three months ended June 30, 2025, the Company experienced a net loss and therefore did not report any dilutive share impact.
|
| Schedule of historical dilutive common share equivalents outstanding |
| | | | | | | | As of June 30, | | | | 2026 | | 2025 | | Stock options | | 807,769 | | 3,494,565 | | Unvested restricted stock units | | 1,206,529 | | 83,657 | | Unvested performance based restricted stock units | | 93,478 | | — | | Total | | 2,107,776 | | 3,578,222 | |
|